SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Celgene
Celgene
Newsletters
Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By
Sy Mukherjee
October 1, 2020
Newsletters
The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health
By
Sy Mukherjee
August 16, 2019
Health
Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health
By
Sy Mukherjee
June 24, 2019
Celgene Boosted Price of Top Cancer Drug on Day of Mega-Deal
By
Bloomberg
January 4, 2019
Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever
By
Bloomberg
January 3, 2019
Russian Drugmaker Granted License to Produce Celgene Copycat
By
McKenna Moore
July 11, 2018
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By
Sy Mukherjee
May 17, 2018
Health
Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By
Sy Mukherjee
January 22, 2018
Finance
U.S. Biotech Firm Celgene to Buy Impact Biomedicines for up to $7 Billion
By
Reuters
January 8, 2018
Health
This 31-Year-Old CEO Is Snapping Up Drug Industry Veterans Left and Right
By
Sy Mukherjee
July 10, 2017
Health
Drug and Device Makers Shelled Out $8 Billion to Doctors and Hospitals Last Year
By
Sy Mukherjee
July 6, 2017
Finance
The 3 Best Health Care and Pharma Stocks for 2017—Whatever Happens to Obamacare
By
Jen Wieczner
December 1, 2016
Health
AI Takes On Drug Safety
By
Sy Mukherjee
and
Clifton Leaf
November 1, 2016
Health
Here’s the Surprising Reason IBM Is Partnering With Celgene
By
Clifton Leaf
November 1, 2016
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By
Sy Mukherjee
August 1, 2016
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
By
Jessica Coacci
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg